When lower price cards might help alleviate the stress of large drug costs while in the short-term, they do not handle the systemic concerns driving up prescription rates in the U.S. Broader coverage adjustments could deal with the root results in of mounting drug prices, such as deficiency of transparency in pricing and also the job of intermediar